Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...

Award-winning "Pose" star Billy Porter announced he was HIV-positive on Wednesday, adding that he was healthy and unashamed ...

The findings mean that for those using preexposure prophylaxis with gender-affirming hormone therapy or long-acting hormonal ...

Introduction Saskatchewan is facing a public health crisis driven by high rates of HIV, syphilis and hepatitis C virus (HCV) infections, particularly among people who use drugs. Injection drug use is ...

A slum-based healthcare rightsorganisation wants the new HIV prevention drug to be first rolled out in poorneighbourhoods to bear much of the epidemic’s brunt.The lobby also wants healthcare workers ...

GLAAD--the world's largest lesbian, gay, bisexual, transgender, and queer (LGBTQ) media advocacy organization––invited Snoop ...

Oral HIV pre-exposure prophylaxis (PrEP) adoption varies across the US, with posters presented at the Academy of Managed Care Pharmacy Nexus 2025 meeting in National Harbor, Maryland, highlighting ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

The first ever injectable drug that can prevent HIV has been approved for use in England and Wales. The drug, cabotegravir, would benefit an estimated 1,000 people at risk of HIV in England and Wales.

Despite meaningful progress in HIV prevention, the HIV epidemic is far from over, with 31,000 new diagnoses in the U.S. each year. HIV prevention medicine, also known as Pre-Exposure Prophylaxis or ...

The National Institute for Health and Care Excellence (NICE) has recommended cabotegravir (Apretude, ViiV Healthcare), an injectable form of preexposure prophylaxis (PrEP), marking a major milestone ...